Examples of prescriptions: wolfberry fruit-killing pills: wolfberry fruit 21g, betel nut 21g, red vine 21g, one hundred one 21g, bitter buckwheat skin 21g, realgar 3g, garlic 9g (juice) powdered into powder, each serving 12g, 3 times a day Even for 2 to 3 days. Note: 1. The sources of wolfberry fruit are "Zhejiang Traditional Chinese Medicine Handbook" and "Chinese Herbal Medicine". Both are designated as the mature seed of the yew tree of the taxaceae family. The "China Higher Plant Pictorial Book" was designated as a Chinese yew plant. 2. A kind of sweet squid produced in Zhuji and Fengqiao of Zhejiang Province. Its fruit is slender and its ends are sharp. The flesh is crunchy and fragrant. It is often used as a non-staple food and can also be used medicinally. 3. Notes in the notes of “Chinese Medicine Chroniclesâ€, Guizhou, Anhui, and other provinces once discovered that the seeds of harringtonine were filled with wolfberry fruit. This product is spindle-shaped, 2 to 2.5 cm long, 1 to 1.3 cm wide, gray brown appearance, endosperm ribbed. The "China Higher Plant Pictorial Book" is also collected, and cloud: Seeds containing more than 30% oil, medicine has lungs, cough, consumer product effect. Palbociclib is a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Palbociclib Intermediates,Cas 571188-59-5,Cas 1013916-37-4,Cas 1016636-76-2 Nanjing Sunshine Biotech Co., Ltd , https://www.sunshine-bio.com
It was reviewed and approved under the Food and Drug Administration`s (FDA) accelerated Priority Review and Breakthrough Therapy designation programs on February 3, 2015 as a treatment (in combination with letrozole) for patients with estrogen receptor positive advanced breast cancer.
We produce a series of complete intermediates for Palbociclib, intermediate I (CAS No. 571188-59-5), intermediate II (CAS No. 1013916-37-4) and intermediate III (CAS No. 1016636-76-2) etc.
